Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO & President, Director
-
Stock Symbol
-
VRTX on Nasdaq
Reshma Kewalramani - trading volume in the past year for Vertex Pharmaceuticals Inc / Ma
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
106K |
$50.8M |
$479.61 |
Feb 26, 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
0 |
$0 |
$81.54 |
May 24, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.